Abstract | PURPOSE: METHODS: A 48-year-old woman was injected with intravitreal bevacizumab 10 times in her right eye with 4 weeks to 6 weeks intervening between injections. Improvement was monitored by best-corrected visual acuity and ocular coherence tomography. RESULTS: Visual acuity improved from 20/200 to 20/30 in the right eye, and foveal thickness improved from 638 μm to 200 μm. Visible signs of macular edema and inflammation completely disappeared. CONCLUSION:
|
Authors | Jon L Hager, Richard A Lewis, H Michael Lambert |
Journal | Retinal cases & brief reports
(Retin Cases Brief Rep)
Vol. 7
Issue 1
Pg. 108-10
( 2013)
ISSN: 1937-1578 [Electronic] United States |
PMID | 25390538
(Publication Type: Journal Article)
|